USP Therapeutic Categories Model Guidelines
| Therapeutic Category | Pharmacologic Class | Formulary Key Drug Types |
|---|---|---|
| Analgesics | Non-opioid Analgesics | |
| Opioid Analgesics | Opioid Analgesics, Long-acting | |
| Opioid Analgesics, Short-acting | ||
| Anesthetics | Local Anesthetics | |
| Antibacterials | Aminoglycosides | |
| Beta-lactam, Cephalosporins | Cephalosporin Antibacterials, 1st Generation | |
| Cephalosporin Antibacterials, 2nd Generation | ||
| Cephalosporin Antibacterials, 3rd Generation | ||
| Cephalosporin Antibacterials, 4th Generation | ||
| Beta-lactam, Penicillins | Amino Derivative Penicillins | |
| Extended Spectrum Penicillins | ||
| Natural Penicillins | ||
| Penicillinase-resistant Penicillins | ||
| Beta-lactam, Other | ||
| Macrolides | Erythromycins | |
| Ketolides | ||
| Macrolides (Non-erythromycins, Non-ketolides) | ||
| Quinolones | ||
| Sulfonamides | ||
| Tetracyclines | ||
| Antibacterials, Other | Antifolate Antibacterials | |
| Glycopeptide Antibacterials | ||
| Lincomycin Antibacterials | ||
| Nitrofuran Antibacterials | ||
| Oxazolidinone Antibacterials | ||
| Miscellaneous Antibacterials | ||
| Anticonvulsants | Calcium Channel Modifying Agents | |
| Gamma-aminobutyric Acid (GABA) Augmenting Agents | ||
| Glutamate Reducing Agents | ||
| Sodium Channel Inhibitors | ||
| Anticonvulsants, Other | ||
| Antidementia Agents | Cholinesterase Inhibitors | |
| Glutamate Pathway Modifiers | ||
| Antidementia Agents, Other | ||
| Antidepressants | Monoamine Oxidase Inhibitors | |
| Serotonin/Norepinephrine Reuptake Inhibitors | ||
| Tricyclics | ||
| Antidepressants, Other | ||
| Antidotes, Deterrents, and Toxicologic Agents | Antidotes | |
| Deterrents | Alcohol Deterrents | |
| Smoking Cessation Agents | ||
| Toxicologic Agents | Opioid Antagonists | |
| Antiemetics | 5-Hydroxytryptamine 3 (5-HT3) Antagonists | |
| Neurokinin 1 (NK1) Receptor Antagonists | ||
| Antiemetics, Other | ||
| Antifungals | Allylamine Antifungals | |
| Azole Antifungals | ||
| Echinocandin Antifungals | ||
| Polyene Antifungals | ||
| Antifungals (Other) | ||
| Antigout Agents | Renal Tubular Blocking Agents | |
| Xanthine Oxidase Inhibitors | ||
| Antigout Agents (Non-renal Tubular Blocking Agents and Non-xanthine Inhibitors) | ||
| Anti-inflammatory Agents | Glucocorticoids | |
| Nonsteroidal Anti-inflammatory Drugs | ||
| Antimigraine Agents | Abortive | Ergot Alkaloids |
| Triptans | ||
| Prophylactic | Beta-adrenergic Blocking Agents | |
| Antimigraine Agents, Prophylactic (Non–beta-adrenergic Blocking Agents) | ||
| Antimyasthenic Agents | Parasympathomimetics | |
| Antimycobacterials | Antituberculars | |
| Antimycobacterials, Other | ||
| Antineoplastics | Alkylating Agents | Ethylenimines/ Methylmelamines |
| Nitrogen Mustards | ||
| Nitrosoureas | ||
| Alkylating Agents, Other | ||
| Antiangiogenic Agents | ||
| Antiestrogens/Modifiers | Estrogen-nitrosoureas | |
| Selective Estrogen Receptor Modulators, 1st Generation | ||
| Antimetabolites | Purine Analogs and Related Inhibitors | |
| Antimetabolites, Other | ||
| Aromatase Inhibitors, 3rd Generation | ||
| Molecular Target Inhibitors | Epidermal Growth Factor Receptor Kinase Inhibitors | |
| Multitargeted Kinase Inhibitors, Bcr-Abl/c-kit Receptor Tyrosine Kinases | ||
| Multitargeted Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor Tyrosine Kinases | ||
| Monoclonal Antibodies | Anti-CD20 Antibodies | |
| Retinoids | ||
| Antineoplastics, Other | ||
| Antiparasitics | Anthelmintics | |
| Antiprotozoals | Antimalarials | |
| Antiprotozoals (Non-antimalarials) | ||
| Pediculicides/ Scabicides | ||
| Antiparkinson Agents | Anticholinergics | |
| Catechol O-methyltransferase (COMT) Inhibitors | ||
| Dopamine Agonists, Ergot | ||
| Dopamine Agonists, Nonergot | ||
| Dopamine Precursors | ||
| Monoamine Oxidase B (MAO-B) Inhibitors | ||
| Antiparkinson Agents, Other | ||
| Antipsychotics | Atypicals | |
| Conventional | ||
| Antispasticity Agents | ||
| Antivirals | Anti-cytomegalovirus (CMV) Agents | |
| Antihepatitis Agents | ||
| Antiherpetic Agents | ||
| Anti-human Immunodeficiency Virus (HIV) Agents, Fusion Inhibitors | ||
| Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors | ||
| Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors | ||
| Anti-HIV Agents, Protease Inhibitors | ||
| Anti-influenza Agents | ||
| Anxiolytics | Antidepressants | |
| Anxiolytics, Other | ||
| Bipolar Agents | ||
| Blood Glucose Regulators | Antidiabetic Agents | Alpha Glucosidase Inhibitors |
| Amylinomimetics | ||
| Biguanides | ||
| Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | ||
| Incretin Mimetics | ||
| Meglitinides | ||
| Sulfonylureas | ||
| Thiazolidinediones | ||
| Glycemic Agents | ||
| Insulins | Insulin, Rapid-acting | |
| Insulin, Short-acting | ||
| Insulin, Intermediate-acting | ||
| Insulin, Long-acting | ||
| Insulin Mixtures, Short-acting and Intermediate-acting | ||
| Insulin Mixtures, Analogs | ||
| Blood Products/Modifiers/Volume Expanders | Anticoagulants | Anticoagulants, Oral |
| Factor Xa Inhibitors, Indirect | ||
| Low Molecular Weight Heparins | ||
| Blood Formation Products | Colony Stimulating Factors | |
| Erythropoietins | ||
| Coagulants | Protease Inhibitors | |
| Platelet Aggregation Inhibitors | Adenosine Diphosphate P2Y12 Inhibitors | |
| Cyclic Adenosine Monophosphate Reuptake Inhibitors | ||
| Phosphodiesterase III/Adenosine Uptake Inhibitors | ||
| Cardiovascular Agents | Alpha-adrenergic Agonists | |
| Alpha-adrenergic Blocking Agents | ||
| Antiarrhythmics | Antiarrhythmics - Classes IA, B, and C | |
| Antiarrhythmics - Class Ia/II/III/IV | ||
| Antiarrhythmics - Class II | ||
| Antiarrhythmics - Class II/III | ||
| Antiarrhythmics - Class III | ||
| Antiarrhythmics - Class IV | ||
| Beta-adrenergic Blocking Agents | Alpha-beta–adrenergic Blocking Agents | |
| Cardioselective Beta-adrenergic Blocking Agents | ||
| Nonselective Beta-adrenergic Blocking Agents | ||
| Calcium Channel Blocking Agents | Calcium Channel Blocking Agents (Non-dihydropyridines) | |
| Dihydropyridines | ||
| Diuretics | Carbonic Anhydrase Inhibitors | |
| Loop Diuretics | ||
| Potassium-sparing Diuretics | ||
| Thiazide Diuretics | ||
| Dyslipidemics | Bile Acid Sequestrants | |
| Cholesterol Absorption Inhibitors | ||
| Fibrates | ||
| 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) Reductase Inhibitors | ||
| Nicotinic Acid | ||
| Omega-3 Fatty Acids | ||
| Renin-angiotensin-aldosterone System Inhibitors | Aldosterone Receptor Antagonists | |
| Angiotensin-converting Enzyme (ACE) Inhibitors | ||
| Angiotensin II Receptor Antagonists | ||
| Vasodilators | Vasodilators, Direct-acting Arterial | |
| Vasodilators, Direct-acting Arterial/Venous | ||
| Vasodilators, Endothelin Receptor Antagonists | ||
| Cardiovascular Agents, Other | ||
| Central Nervous System Agents | Amphetamines, ADHD | |
| Non-amphetamines, ADHD | ||
| Non-amphetamines, Other | ||
| Dental and Oral Agents | ||
| Dermatological Agents | Dermatological Acne Agents | |
| Dermatological Anti-inflammatory Agents | ||
| Dermatological Antipruritic Agents | ||
| Dermatological Calcineurin Inhibitors | ||
| Dermatological Caustic Agents | ||
| Dermatological Emollients | ||
| Dermatological Genital Wart Agents | ||
| Dermatological Mitotic Inhibitors | ||
| Dermatological Non-melanoma Skin Cancer Agents | ||
| Dermatological Photochemotherapy Agents | ||
| Dermatological Psoriasis Agents | ||
| Dermatological Wound Care Agents | ||
| Enzyme Replacements/Modifiers | Anti-cystine Agents | |
| Fabry Disease Treatment | ||
| Gaucher's Disease Treatment | ||
| Glucosylceramide Synthase Inhibitors | ||
| Hereditary Tyrosinemia Type 1 (HT-1) Treatment | ||
| Homocystinuria Treatment | ||
| Hunter Syndrome Treatment | ||
| Mucopolysaccharidosis Disease Treatment | ||
| Pancrelipase Replacement | ||
| Severe Combined Immunodeficiency Disease (SCID) Treatment | ||
| Sucrase Enzyme Replacement | ||
| Urea Cycle Disorder Treatment | ||
| Gastrointestinal Agents | Antispasmodics, Gastrointestinal | |
| Histamine2 (H2) Blocking Agents | ||
| Irritable Bowel Syndrome Agents | ||
| Protectants | ||
| Proton Pump Inhibitors | ||
| Gastrointestinal Agents, Other | ||
| Genitourinary Agents | Antispasmodics, Urinary | |
| Benign Prostatic Hypertrophy Agents | Alpha 1-adrenergic Blocking Agents | |
| 5 Alpha-reductase Inhibitors | ||
| Phosphate Binders | ||
| Genitourinary Agents, Other | ||
| Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal) | Glucocorticoids/ Mineralocorticoids | Glucocorticoids-Systemic |
| Glucocorticoids-Topical-Low Potency | ||
| Glucocorticoids-Topical-Medium Potency | ||
| Glucocorticoids-Topical-High Potency | ||
| Glucocorticoids-Topical-Very High Potency | ||
| Mineralocorticoids | ||
| Hormonal Agents, Stimulant/ Replacement/ Modifying (Pituitary) | Gonadotropins | |
| Growth Hormone Analogs | ||
| Insulin-like Growth Factor Analogs | ||
| Vasopressin Analogs | ||
| Hormonal Agents, Stimulant/ Replacement/ Modifying (Prostaglandins) | ||
| Hormonal Agents, Stimulant/ Replacement/ Modifying (Sex Hormones/ Modifiers) | Anabolic Steroids | |
| Androgens | ||
| Estrogens | ||
| Progestins | ||
| Selective Estrogen Receptor Modifying Agents | ||
| Hormonal Agents, Stimulant/ Replacement/ Modifying (Thyroid) | ||
| Hormonal Agents, Suppressant (Adrenal) | ||
| Hormonal Agents, Suppressant (Parathyroid) | Calcimimetics | |
| Hormonal Agents, Suppressant (Pituitary) | Dopamine Agonists | |
| Gonadotropin-releasing Hormone Analogs | ||
| Growth Hormone Antagonists | ||
| Somatostatin Analogs | ||
| Hormonal Agents, Suppressant (Sex Hormones/ Modifiers) | Antiandrogens | |
| Hormonal Agents, Suppressant (Thyroid) | Antithyroid Agents | |
| Immunological Agents | Immune Stimulants | Vaccines to Prevent Anthrax |
| Vaccines to Prevent Diphtheria | ||
| Vaccines to Prevent Haemophilus Type B | ||
| Vaccines to Prevent Hepatitis A | ||
| Vaccines to Prevent Hepatitis B | ||
| Vaccines to Prevent Japanese Encephalitis | ||
| Vaccines to Prevent Measles | ||
| Vaccines to Prevent Meningococcal Disease | ||
| Vaccines to Prevent Mumps | ||
| Vaccines to Prevent Papillomavirus Disease | ||
| Vaccines to Prevent Pertussis | ||
| Vaccines to Prevent Poliovirus | ||
| Vaccines to Prevent Rabies | ||
| Vaccines to Prevent Rotavirus Disease | ||
| Vaccines to Prevent Rubella | ||
| Vaccines to Prevent Tetanus | ||
| Vaccines to Prevent Typhoid | ||
| Vaccines to Prevent Varicella | ||
| Vaccines to Prevent Yellow Fever | ||
| Vaccines to Prevent Zoster | ||
| Immune Suppressants | Immune Suppressants (Non-TNF Inhibitors) | |
| Tumor Necrosis Factor (TNF) Inhibitors | ||
| Immunizing Agents, Passive | Immunoglobulins | |
| Immunomodulators | Interferons, Alfa | |
| Interferons, Beta | ||
| Interferons, Gamma | ||
| Immunomodulators, Other | ||
| Inflammatory Bowel Disease Agents | Glucocorticoids | |
| Salicylates | ||
| Sulfonamides | ||
| Metabolic Bone Disease Agents | Bisphosphonates, Oral | |
| Bisphosphonates, Parenteral | ||
| Calcium Regulating Hormones | ||
| Parathyroid Hormone Analogs | ||
| Vitamin D–related Agents/Metabolic Bone Disease Agents | ||
| Ophthalmic Agents | Ophthalmic Anti-allergy Agents | |
| Ophthalmic Antiglaucoma Agents | Alpha-adrenergic Agonists, Ophthalmic | |
| Beta-adrenergic Blocking Agents, Ophthalmic | ||
| Carbonic Anhydrase Inhibitors, Ophthalmic | ||
| Cholinergic Agonists, Ophthalmic | ||
| Ophthalmic Anti-inflammatories | Glucocorticoids, Ophthalmic | |
| Nonsteroidal Anti-inflammatory Drugs, Ophthalmic | ||
| Ophthalmic Prostaglandin and Prostamide Analogs | ||
| Ophthalmic Agents, Other | ||
| Otic Agents | Otic Anti-inflammatories | |
| Respiratory Tract Agents | Antihistamines | Histamine1 (H1) Blocking Agents, Mildly/Non-sedating |
| H1 Blocking Agents, Sedating | ||
| Anti-inflammatories, Inhaled Corticosteroids | ||
| Antileukotrienes | Receptor Antagonists | |
| Synthesis Inhibitors | ||
| Bronchodilators, Anticholinergic | ||
| Bronchodilators, Phosphodiesterase Inhibitors (Xanthines) | ||
| Bronchodilators, Sympathomimetic | ||
| Mast Cell Stabilizers | ||
| Pulmonary Antihypertensives | ||
| Respiratory Tract Agents, Other | ||
| Sedatives/Hypnotics | ||
| Skeletal Muscle Relaxants | ||
| Therapeutic Nutrients/Minerals/ Electrolytes | Electrolytes/Minerals | |
| Vitamins | Prenatal Vitamins |